- $45.51bn
- $37.56bn
- $6.85bn
- 72
- 15
- 60
- 47
RCS - Moderna Inc - EMA Adopts Positive Opinion of Covid-19 Vaccine
AnnouncementREG - Official List - Official List Amendment - Leverage Shares PLC
AnnouncementREG - Stock Exch Notice - Admission to Trading - 08/09/2023
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 17/08/2023
AnnouncementREG - Stock Exch Notice - Admission to Trading - 16/08/2023
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 24/07/2023
AnnouncementREG - Leverage Shares PLC Leverage3XLongMrna$ Leverage3XLongMrna£ Leverage3XLongMrnaE - Result adjourn meet LS 3xLong Moderna(MRNA)ETP Ses
AnnouncementREG - Stock Exch Notice - Admission to Trading - 12/07/2023
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 11/07/2023
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Leverage Shares PLC Leverage3XLongMrna$ Leverage3XLongMrna£ Leverage3XLongMrnaE - ETP Securityholder meeting LS 3xLong Moder (MRNA)
AnnouncementRCS - Moderna Inc - Moderna Announces Global Regulatory Submissions
AnnouncementRCS - Moderna Inc - Moderna Submits Filing to EMA for COVID-19 Vaccine
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 29/06/2023
Announcement